Bismuth (Pepto Bismol, Kaopectate) Side Effects & Dosage

What is bismuth subsalicylate-oral, and how does it work (mechanism of action)?

Bismuth subsalicylate (BSS) is a commonly used over
the counter medicine used to treat:

Bismuth subsalicylate is also used to prevent traveler’s diarrhea
and to treat Helicobacter pylori (H. pylori) infection as part of a
quadruple-drug therapy that also includes two antibiotics, and either a
histamine-2 receptor antagonist or proton pump inhibitor.

Bismuth subsalicylate has various therapeutic benefits in the body including
anti-bacterial, weak antacid, anti-inflammatory, and anti-secretory actions.
After oral administration, bismuth subsalicylate is degraded in the stomach to
produce salicylic acid. Salicylic acid inhibits the synthesis of prostaglandin,
a chemical made in the body that plays an important role in contraction of
smooth muscle and relaxation, dilation & constriction of blood vessels, blood
pressure control, and modulation of inflammation.

The antidiarrheal benefits of bismuth subsalicylate may be due to the
reduction in prostaglandin synthesis. Bismuth subsalicylate also prevents the
attachment of bacteria to the walls of the intestine, inactivates enterotoxins
(toxic chemicals made by bacteria), and has a direct inhibiting effect on
bacteria.

Bismuth subsalicylate was first approved by the FDA in 1939.

What brand names are available for bismuth subsalicylate?

Bismatrol Maximum Strength, Pepto Bismol, Kaopectate,
and many other brands

Is bismuth subsalicylate-oral available as a generic drug?

Yes

Do I need a prescription for bismuth subsalicylate?

What are the side effects of bismuth subsalicylate-oral?

Dark brown or black stools are common with use of bismuth
subsalicylate. Tongue discoloration and constipation also may occur.

Other side effects associated with bismuth subsalicylate include:

QUESTION

Pancreatitis is inflammation of an organ in the abdomen called the pancreas.
See Answer

What is the dosage for bismuth subsalicylate-oral?

Over-the-counter treatment of nonspecific diarrhea in adults and adolescents
(= 12 years):

Chewable tablets, caplets, liquids containing
262 mg/15 ml: 524 mg by mouth every 30-60 minutes as needed. Not to exceed 8
doses in 24 hours.
Liquids containing 525 mg/15 ml: 1050 mg by
mouth every hour as needed. Not to exceed 4 doses in 24 hours.
Over-the-counter treatment of upset stomach, heartburn, indigestion, nausea,
and related symptoms in adults and adolescents (= 12 years):
Chewable tablets, caplets, liquids containing
262 mg/15 ml: 524 mg by mouth every 30-60 minutes as needed. Not to exceed 8
doses in 24 hours.
Liquids containing 525 mg/15 ml: 1050 mg by
mouth every hour as needed. Not to exceed 4 doses in 24 hours.
For the prevention of traveler‘s diarrhea due to
Escherichia coli
(E. coli) and viral
infections in adults and adolescents (≥ 12 years):
524 mg by mouth four times daily, starting 1
day before departure and continuing for 2 days after returning. Generally,
treatment duration should not exceed 3 weeks.
For the eradication of helicobacter pylori as part of quadruple-drug regimen
in adults and adolescents (≥ 12 years):
525 mg by mouth 4 times daily.

The safety and effectiveness of bismuth subsalicylate use in children <12
years has not been established.

Latest Digestion News

Trending on MedicineNet

Which drugs or supplements interact with bismuth subsalicylate-oral?

Combining bismuth subsalicylate with sulfinpyrazone (Anturane) or probenecid
is not recommended because bismuth subsalicylate may suppress the therapeutic
effects of both drugs.

Tetracycline and quinolone antibiotics may form insoluble complexes with
bismuth subsalicylate. While bismuth subsalicylate should be avoided in patients
taking these antibiotics if possible, separating administration by 2 hours may
be sufficient to avoid this interaction.

Bismuth subsalicylate should be used cautiously in patients taking
methotrexate (Trexall). Bismuth subsalicylate is broken down to salicylic acid
which is known to increase blood levels of methotrexate. Patients especially at
risk for this interaction include those on high-dose methotrexate therapy,
elderly patients, and patients with reduced kidney function.

Bismuth subsalicylate is broken down to salicylic acid. Pediatric patients
should not be given salicylates for 6 weeks after receiving the varicella-zoster
virus live vaccine (Zostavax, Varivax) due to the risk of developing Reye’s
syndrome, a serious
liver disease.

Is bismuth subsalicylate-oral safe to take if I’m pregnant or breastfeeding?

Bismuth subsalicylate is known to cross the placenta following
oral administration. Use of salicylates during pregnancy has been associated
with adverse effects in the fetus. Therefore use of bismuth subsalicylate during
pregnancy should be avoided. Bismuth subsalicylate is classified as FDA
pregnancy risk category C (adverse effects in animals but inadequate human
data).

Salicylates are excreted into human milk and can cause harm
to the nursing infant. Bismuth subsalicylate is thought to be harmful to the
nursing infant and should be avoided during breastfeeding.

What else should I know about bismuth subsalicylate-oral?

What preparations of bismuth subsalicylate-oral are available?

Chewable tablets: 262, 525 mg
Oral suspension: 262 mg/15 ml, maximum strength 525 mg/15 ml
Caplets: 262 mg

How should I keep bismuth subsalicylate-oral stored?

Bismuth subsalicylate products should be stored at room temperature,
between 59 F to 86 F (15 C to 30 C).